Published in
Dustri-Verlag, Clinical Neuropathology, 09(39), p. 203-211, 2020
DOI: 10.5414/np301278
Links
Tools
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019
Journal article published in 2020 by
Markus J. Riemenschneider,
Josephine Fischer,
Maja Grassow-Narlik,
Christian Mawrin,
Andreas von Deimling 
,
Torsten Pietsch,
Guido Reifenberger,
Wolf C. Mueller,
Clemens J. Sommer,
Manfred Dietel,
Saida Zoubaa,
Julia Lorenz,
Tanja Rothhammer-Hampl
,
Torsten Pietsch,
Guido Reifenberger,
Wolf C. Mueller,
Clemens J. Sommer,
Manfred Dietel,
Saida Zoubaa,
Julia Lorenz,
Tanja Rothhammer-Hampl
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 